In addition, conflicting results are being reported regarding the prognosis of patients with NAFLD-related hepatocellular carcinoma and high expression of programmed cell death 1/programmed cell death 1 ligand 1. This evidence concerns the gene PDCD1 and metabolic dysfunction-associated steatotic liver disease.